Is Tecnoglass Stock a Buy After Energy Holdings Scooped Up Shares Worth $13.1 Million? This architectural glass manufacturer, serving major markets across the Americas, reported a recent insider buy in official filings.
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.
This F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround? This annuities and life insurance provider saw a notable insider buy amid a year marked by sharp share price declines and sector headwinds.
Should You Buy Lockheed Martin While It's Up 26% in 2026? If the defense budget tops $1 trillion, Lockheed stands to make a fortune.
Why Argan Stock Ascended Today Data centers devour energy. Argan builds the power plants that feed them.
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know LeMaitre Vascular, a specialist in vascular medical devices, reported a notable insider sale amid strong recent share gains.
Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More This biotech specializing in endocrine therapies reported a notable insider sale as it advances clinical-stage drug candidates.
Alphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should Know This spine-focused medtech firm, known for its surgical innovations, reported a notable insider sale amid ongoing portfolio expansion.
Only a Few "Magnificent Seven" Stocks Look Like Buys Right Now. This Is One of Them. As stocks sell off, here's one of the Magnificent Seven stocks I think has fallen enough to make it a buy.
The Market Is Down 5% in 2026. Here's the Best Dividend Stock to Buy With $10,000 Right Now. This investment offers a terrific combination of likely price appreciation along with dividend income.
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.
Why Argan Stock Was a Winner This Week The company crushed bottom-line estimates in its final quarter of 2025.
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.
Unfortunate News for Meta Stock Investors Investors are concerned about restrictive regulations against social media companies.
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena Could Novo Nordisk be the hidden gem you've been searching for? Join us as we evaluate its current market position and future prospects in this insightful episode.
Is Alphabet Stock Still a Buy? The war in Iran is driving widespread selling in the stock market.
Is e.l.f. Stock a Generational Buying Opportunity? Trader barriers are increasing import prices for most businesses, including e.l.f.
Why Gartner Stock Sagged Today One analyst tracking the stock shaved $10 off his price target.
Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year Specializing in CNS therapies, this biopharma firm reported a notable insider sale amid a year of strong stock performance.
Only 1 of These Top 2 REITs Is Built to Pay You for Generations VICI or Realty Income? One offers higher yield and growth, while the other may benefit more when rate cuts arrive.
TechnipFMC Defies Market, Hits Record High, Leads 16 Top Performers To IBD Best Stock Lists The major markets fell into a correction Friday but TechnipFMC rose to a record high. The U.K. company provides gear to oil companies.
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 Specializing in branded and generic pharmaceuticals, this sector player reported a notable insider sale amid a stable transaction pattern.
